Return to content in this issue

 

A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab

Nucera E1*, Basta F2*, Buonomo A1, Mezzacappa S1, Margiotta DP2, Antonelli Incalzi R3, Schiavino D1

1Allergy Unit, Università Cattolica del Sacro Cuore - Policlinico “A. Gemelli”, Rome, Italy
2Unit of Allergology, Immunology and Rheumatology, Department of Medicine, Campus Bio-Medico di Roma University, Rome, Italy
3Unit of Geriatrics, Campus Bio-Medico University, Rome, Italy
*Both authors contributed equally to the manuscript.

J Investig Allergol Clin Immunol 2017; Vol 27(6) : 382-384
doi: 10.18176/jiaci.0191

Key words: HUVS, Omalizumab, Hypocomplementemic urticarial vasculitis syndrome, Chronic urticarial, Lupus